Tamperloks

  • Neopharma Technologies Tamperloks drug testing cup is the new global benchmark in drugs of abuse urine testing technology
  • Interlocking lid and seal to ensure the device is not tampered with after sample is collected, and can be safely sent to the lab for a confirmatory testing
  • Unique triple chamber design ensures device is 100% LEAK and ODOUR proof to ensure hygiene and minimize risk of compromising the sample during transportation and preventing retesting
  • Temperature test strip to ensure that the sample collected is a fresh sample
  • Adulteration strip is part of the test to ensure the sample is not compromised
  • Interlocking ring is included to ensure that the device is not accidentally locked before use
  • Digitally enabled by the NEOVAULT app, which is available for download via apple and google
  • Unique dynamic QR code with a serial number
  • Fully integrated with the NEOVAULT ERP software platform providing electronic CHAIN OF CUSTODY and digital reporting

What is NEOVAULT?

myNEO

myNEO is available on Google Play and Apple App Store.
DRUG TESTING DEVICE

Intended Use

The TamperLoks Drug Testing Device is a tamperproof lateral flow chromatographic immunoassay for the detection of drugs of abuse and drugs of abuse metabolites in urine. All drug test strips assembled in the TamperLoks Device will be as specified by the user. This assay provides only a preliminary analytical test result.A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug test result, particularly when preliminary positive results are indicated. The device is for professional use.

Principle

The TamperLoks Drug Testing Device is an immunoassay based on the principle of competitive binding. Drugs of abuse which may be present in the urine specimen compete against the drug conjugate for binding sites on the antibody. During testing, the urine specimen migrates upward through capillary action. The drugs, if present in the urine specimen below its cut-off concentration, will not saturate the binding sites of its specific antibody. The antibody will then react with the drug-protein conjugate and a visible colored line will appear in the test line above the specific drug test strip. The presence of drugs above the cut-off concentration will saturate all the binding sites of the antibody. Therefore, the colored line will not form in the test line region. To serve as a procedural control, a colored line will always appear at the control line region indicating the proper volume of specimen has been added and membrane wicking has occurred.

Reagents

Each test contains a membrane strip coated with drug-protein conjugates (purified bovine albumin) on the test line; a goat polyclonal antibody against gold-protein conjugate at the control line; and a dye pad which contains colloidal gold particles coated with mouse monoclonal antibody specific to Amphetamine, Cocaine, Methamphetamine, Methylenedioxymethamphetamine, Tricyclic Antidepressants, Morphine, THC, Phencyclidine, Benzodiazepine, Methadone or Barbiturate depending on the drug tests specified by the user to be tested.

Storage And Stability

Store as packed in the sealed pouch at 2-30°C/35.6-86°F. The test is stable through the expiration date printed on the sealed pouch. The TamperLoks Test Device must remain in the sealed pouch until use. DO NOT FREEZE. Shelf life: 18 months from date of manufacture.

Precautions

For in vitro diagnostic use only. Do not use after the expiration date. All specimens should be considered potentially hazardous and handled in the same manner as an infectious agent. The used test device should be discarded according to local regulations.

Interpretation of results

POSITIVE: One red line appears in the control region (C). No line appears in the test region (T). This positive result indicates the drug concentration is above the detectable level. Please refer to the Illustration above.

NEGATIVE: Two lines appear. One red line should be in the control region (C), and another red or weak pink line adjacent appears in the test region (T). This negative result indicates the drug concentration is below the detectable level.

*NOTE: The shade of red in the test line region (T) may vary, but it should be considered negative whenever there is even a faint pink line. Please refer to the Illustration above.

INVALID: Control line fails to appear. Incorrect procedural techniques are the most likely reasons for control line failure. Review the procedure and repeat the test using a new test device. If the problem persists, discontinue using the lot immediately and contact your local distributor. Please refer to the Illustration above. The results can be read for a period of up to 10 minutes. DO NOT INTERPRET RESULTS AFTER 10 MINUTES as they will no longer be valid.

HOW TO CONFIRM

Test Results in the Laboratory

SPECIMEN

Collection And Preparation

Urine Assay

The urine specimen must be collected in a clean and dry TamperLoks Device, specifically in the Upper Collection Chamber. The test can be conducted with urine samples taken at any time of the day. Urine specimens exhibiting visible precipitates should be centrifuged, filtered, or allowed to settle to obtain a clear specimen for testing.

Specimen Storage

Urine specimens may be stored at 2-8°C/35.6-46.4°F for up to 48 hours prior to testing. For prolonged storage, specimens may be frozen and stored below -20°C/-4°F. Frozen specimens should be thawed and mixed completely before testing.
HOW TO USE

Tamperlok test device

Limitations

  1. The TamperLoks Drug Testing Device provides only a qualitative, preliminary, analytical result. A secondary analytical method must be used to obtain a confirmed result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method.
  2. It is possible that technical or procedural errors, as well as other interfering substances in the urine specimen, may cause erroneous results.
  3. Adulterants such as bleach and/or alum in urine specimens may produce erroneous results regardless of the analytical method used. If adulteration is suspected, the test should be repeated with another urine specimen.
  4. A positive result indicates presence of the drug or its metabolites but does not indicate level of intoxication, administration route or concentration in urine.
  5. A negative result may not necessarily indicate drug-free urine. Negative results can be obtained when drug is present but below the cut-off level.